Globus Medical (GMED) Current Deferred Revenue (2017 - 2026)

Globus Medical (GMED) has 10 years of Current Deferred Revenue data on file, last reported at $34.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 103.22% year-over-year to $34.9 million; the trailing twelve-month figure through Mar 2026 stood at $34.9 million (up 103.22% YoY), and the FY2025 full-year result was $36.9 million, up 66.67% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $34.9 million, down from $36.9 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $36.9 million in Q4 2025 and bottomed at $11.8 million in Q1 2022.
• The 5-year median for Current Deferred Revenue is $18.0 million (2023), against an average of $19.3 million.
• The widest annual swing landed in 2025, when Current Deferred Revenue retreated 12.19%; it then surged 103.22% in 2026.
• A 5-year view of Current Deferred Revenue shows it stood at $14.1 million in 2022, then surged by 30.28% to $18.4 million in 2023, then climbed by 20.53% to $22.1 million in 2024, then jumped by 66.67% to $36.9 million in 2025, then dropped by 5.43% to $34.9 million in 2026.
• The last three Current Deferred Revenue figures came in at $34.9 million (Q1 2026), $36.9 million (Q4 2025), and $18.3 million (Q3 2025), per Business Quant data.

Peer Comparison